| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3904494 | Urology | 2010 | 9 Pages |
Abstract
AUCAFP-hCG is a dynamic parameter characterizing tumor marker decline in patients with NSGCT during BEP treatment. Its value as a promising predictive factor should be validated.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Benoit You, Ludivine Fronton, Helen Boyle, Jean-Pierre Droz, Pascal Girard, Brigitte Tranchand, Benjamin Ribba, Michel Tod, Sylvie Chabaud, Henri Coquelin, Aude Fléchon,